ResearcherHarvard UniversityActive in the last 2 years

Ibrahim Ragab Eissa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9454-6327; OpenAlex author ID A5078280466. Sources: OpenAlex.

Their work

Papers: 4
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 11

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 4

The CD49b (ITGA2) collagen receptor excludes CD8+ T cell infiltration in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.isci.2026.116500 ↗
Enhancing mesothelin CAR T cell therapy for pancreatic cancer with an oncolytic herpes virus boosting CAR target antigen expression. Co-author DOI 10.1007/s00262-025-04039-7 ↗
Molecular MRI of Dysregulated Zinc Secretion Detects Pancreatic Ductal Adenocarcinoma and Response to KRASG12D Inhibitor Treatment. Co-author DOI 10.1158/0008-5472.can-24-3384 ↗
C-REV Retains High Infectivity Regardless of the Expression Levels of cGAS and STING in Cultured Pancreatic Cancer Cells. Co-author DOI 10.3390/cells10061502 ↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kenneth K. Tanabe · 2 shared papers, 2025–2026 · strength 0.58
- Paper The CD49b (ITGA2) collagen receptor excludes CD8+ T cell infiltration in pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2026.116500 ↗
- Paper Molecular MRI of Dysregulated Zinc Secretion Detects Pancreatic Ductal Adenocarcinoma and Response to KRASG12D Inhibito… DOI 10.1158/0008-5472.can-24-3384 ↗
Genevieve Marie Boland · 1 shared paper, 2026 · strength 0.39
- Paper The CD49b (ITGA2) collagen receptor excludes CD8+ T cell infiltration in pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2026.116500 ↗
Hideki Kasuya · 2 shared papers, 2021–2025 · strength 0.36
- Paper Enhancing mesothelin CAR T cell therapy for pancreatic cancer with an oncolytic herpes virus boosting CAR target antige… DOI 10.1007/s00262-025-04039-7 ↗
- Paper C-REV Retains High Infectivity Regardless of the Expression Levels of cGAS and STING in Cultured Pancreatic Cancer Cell… DOI 10.3390/cells10061502 ↗
Mona Alhussein Aboalela · 1 shared paper, 2025 · strength 0.25
- Paper Enhancing mesothelin CAR T cell therapy for pancreatic cancer with an oncolytic herpes virus boosting CAR target antige… DOI 10.1007/s00262-025-04039-7 ↗
Veronica Clavijo Jordan · 1 shared paper, 2025 · strength 0.19
- Paper Molecular MRI of Dysregulated Zinc Secretion Detects Pancreatic Ductal Adenocarcinoma and Response to KRASG12D Inhibito… DOI 10.1158/0008-5472.can-24-3384 ↗
Peter D. Caravan · 1 shared paper, 2025 · strength 0.19
- Paper Molecular MRI of Dysregulated Zinc Secretion Detects Pancreatic Ductal Adenocarcinoma and Response to KRASG12D Inhibito… DOI 10.1158/0008-5472.can-24-3384 ↗
Motaz Qadan · 1 shared paper, 2025 · strength 0.19
- Paper Molecular MRI of Dysregulated Zinc Secretion Detects Pancreatic Ductal Adenocarcinoma and Response to KRASG12D Inhibito… DOI 10.1158/0008-5472.can-24-3384 ↗
Nabeel M. Bardeesy · 1 shared paper, 2025 · strength 0.19
- Paper Molecular MRI of Dysregulated Zinc Secretion Detects Pancreatic Ductal Adenocarcinoma and Response to KRASG12D Inhibito… DOI 10.1158/0008-5472.can-24-3384 ↗
Stuti G. Shroff · 1 shared paper, 2025 · strength 0.19
- Paper Molecular MRI of Dysregulated Zinc Secretion Detects Pancreatic Ductal Adenocarcinoma and Response to KRASG12D Inhibito… DOI 10.1158/0008-5472.can-24-3384 ↗
Daishi Morimoto · 1 shared paper, 2021 · strength 0.12
- Paper C-REV Retains High Infectivity Regardless of the Expression Levels of cGAS and STING in Cultured Pancreatic Cancer Cell… DOI 10.3390/cells10061502 ↗
Yasuhiro Kodera · 1 shared paper, 2021 · strength 0.12
- Paper C-REV Retains High Infectivity Regardless of the Expression Levels of cGAS and STING in Cultured Pancreatic Cancer Cell… DOI 10.3390/cells10061502 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.